2 results match your criteria: "McGill Universitygrid.14709.3bgrid.63984.30 Health Centre[Affiliation]"
Preclinical Evaluation of Recombinant Microbial Glycoside Hydrolases as Antibiofilm Agents in Acute Pulmonary Pseudomonas aeruginosa Infection.
Antimicrob Agents Chemother
August 2022
Department of Microbiology and Immunology, McGill Universitygrid.14709.3bgrid.63984.30, Montreal, Quebec, Canada.
The bacterium Pseudomonas aeruginosa can colonize the airways of patients with chronic lung disease. Within the lung, P. aeruginosa forms biofilms that can enhance resistance to antibiotics and immune defenses.
View Article and Find Full Text PDFSpecificity of SARS-CoV-2 Antibody Detection Assays against S and N Proteins among Pre-COVID-19 Sera from Patients with Protozoan and Helminth Parasitic Infections.
J Clin Microbiol
January 2022
Division of Infectious Diseases, Department of Medicine, McGill Universitygrid.14709.3bgrid.63984.30 Health Centre, Montreal, Quebec, Canada.
We aimed to assess the specificity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody detection assays among people with tissue-borne parasitic infections. We tested three SARS-CoV-2 antibody-detection assays (cPass SARS-CoV-2 neutralization antibody detection kit [cPass], Abbott SARS-CoV-2 IgG assay [Abbott Architect], and Standard Q COVID-19 IgM/IgG combo rapid diagnostic test [SD RDT IgM/SD RDT IgG]) among 559 pre-COVID-19 seropositive sera for several parasitic infections. The specificity of assays was 95 to 98% overall.
View Article and Find Full Text PDF